Align Technology reported $4.14B of revenue over the trailing twelve months, +4.4% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $4.14B (to Q2 2026). Net income: $414M, trailing twelve months to Q2 2026. Free cash flow: $634M, trailing twelve months to Q2 2026. Operating margin: 13%, trailing twelve months to Q2 2026.

ALGNAlign Technology

Healthcare

$142.75+7.7% 1Y

$142.75

$124.8852 weeks$197.51

ALGN as reported

Align Technology reported $4.14B of revenue over the trailing twelve months, +4.4% on the year before. 10 reported series are charted on this page, each one as filed.

$4.14B

Revenue, trailing twelve months · to Q2 2026 · +4.4% against the twelve months before

Net income: $414M
Net income · −5.5% year on year · trailing twelve months to Q2 2026
Free cash flow: $634M
Free cash flow · +0.32% year on year · trailing twelve months to Q2 2026
Operating margin: 13%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ALGN, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$4.14B	+4.4%	Q2 2026
Net income	$414M	−5.5%	Q2 2026
EPS	$5.74	−3.2%	Q2 2026
Gross margin	68%	n/a	Q2 2026
Operating margin	13%	n/a	Q2 2026
Net margin	9.9%	n/a	Q2 2026
ROE	10.0%	n/a	Q2 2026
ROA	6.5%	n/a	Q2 2026
Free cash flow	$634M	+0.32%	Q2 2026
P/E	24.9	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.